AI Article Synopsis
- - This study examined 382 patients with metastatic breast cancer (MBC) to explore different monitoring strategies for the disease.
- - Key findings showed that higher levels of baseline serum tumor markers led to more frequent testing, and more frequent oncology visits correlated with increased use of chemotherapy and MRI.
- - The study found that single and older patients had less frequent testing, while those with clinically measurable disease had less intensive monitoring, indicating that monitoring strategies were minimally impacted by clinico-pathological factors.
Article Abstract
A monitoring strategy for metastatic breast cancer patients (M-MBC) has been little studied. This retrospective study analyzed a consecutive cohort of 382 MBC patients to analyze different M-MBC strategies to identify factors influencing intensive M-MBC. Elevated baseline serum tumor markers (STM) was the strongest factor associated with increased use of STM tests. Having more frequent oncology office visits was associated with more intensive chemotherapy/magnetic resonance imaging (MRI) using. Increased use of imaging tests was associated with participation to clinical trial. Single and elderly patients were less likely to have frequent testing. Having clinically measurable disease was less likely to have more intensive M-MBC. STM testing and scans were frequently ordered in M-MBC. In the present study, strategies are little influenced by clinico-pathological characteristics.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2217/fon-2020-0020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!